Filter News
Area of Research
- (-) Computational Biology (1)
- (-) Nuclear Science and Technology (21)
- Advanced Manufacturing (6)
- Biology and Environment (44)
- Building Technologies (1)
- Clean Energy (69)
- Climate and Environmental Systems (1)
- Computational Engineering (3)
- Computer Science (15)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (12)
- Fusion Energy (8)
- Isotope Development and Production (1)
- Isotopes (26)
- Materials (66)
- Materials for Computing (13)
- Mathematics (1)
- National Security (43)
- Neutron Science (21)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (8)
- Sensors and Controls (1)
- Supercomputing (116)
News Topics
- (-) Advanced Reactors (11)
- (-) Computer Science (3)
- (-) Cybersecurity (1)
- (-) Isotopes (5)
- (-) Space Exploration (5)
- 3-D Printing/Advanced Manufacturing (4)
- Artificial Intelligence (1)
- Bioenergy (1)
- Biology (2)
- Biomedical (4)
- Coronavirus (2)
- Decarbonization (1)
- Environment (1)
- Fusion (8)
- High-Performance Computing (2)
- Materials Science (3)
- Molten Salt (4)
- Neutron Science (6)
- Nuclear Energy (36)
- Physics (2)
- Summit (1)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.